Achilles Therapeutics to present at the BofA Securities 2021 Virtual Healthcare Conference
May 05 2021 - 7:30AM
Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage
biopharmaceutical company developing precision T cell therapies to
treat solid tumors, today announced that Iraj Ali, Chief Executive
Officer, will participate in a fireside chat at the BofA Securities
2021 Virtual Healthcare Conference on Thursday, May 13, 2021, at
9:30 a.m. ET / 2:30 p.m. BST.
A live and archived webcast of the presentation
will be available in the Events & Presentations section of
the Achilles website.
About Achilles Therapeutics
Achilles is a clinical-stage biopharmaceutical
company developing precision T cell therapies targeting clonal
neoantigens: protein markers unique to the individual that are
expressed on the surface of every cancer cell. The Company has two
ongoing Phase I/IIa trials, the CHIRON trial in patients with
advanced non-small cell lung cancer (NSCLC) and the THETIS trial in
patients with recurrent or metastatic melanoma. Achilles uses DNA
sequencing data from each patient, together with its proprietary
PELEUS™ bioinformatics platform, to identify clonal neoantigens
specific to that patient, and then develop precision T cell-based
product candidates specifically targeting those clonal
neoantigens.
Further information:
Lee M. Stern – VP, IR & External
Communications+1 (332) 373-2634l.stern@achillestx.com
Consilium Strategic CommunicationsMary-Jane
Elliott, Sukaina Virji, Melissa Gardiner+44 (0) 203 709
5000achillestx@consilium-comms.com
Achilles Therapeutics (NASDAQ:ACHL)
Historical Stock Chart
From Jul 2024 to Aug 2024
Achilles Therapeutics (NASDAQ:ACHL)
Historical Stock Chart
From Aug 2023 to Aug 2024